Cargando…

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes

Detalles Bibliográficos
Autores principales:	Su, B, Biedma, ME, Lederle, A, Lambotin, M, Moog, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441910/ http://dx.doi.org/10.1186/1742-4690-9-S2-P182

Ejemplares similares

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes
por: Xu, K, et al.
Publicado: (2009)

P11-16. Transfer of HIV-1 from Langerhans and interstitial dendritic cells to T lymphocytes: protection mediated by antibodies?
por: Peressin, M, et al.
Publicado: (2009)

P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
por: Yassine Diab, B, et al.
Publicado: (2009)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
por: Fouda, GG, et al.
Publicado: (2012)

Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen
por: Smith, Kellie N, et al.
Publicado: (2012)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009)

Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes
por: Fackler, Oliver
Publicado: (2013)

Tolerogenic dendritic cells differentially modulate naïve and memory CD4(+ )T cells
por: Anderson, Amy E, et al.
Publicado: (2007)

Variable processing and presentation of HIV epitopes in dendritic cells and macrophages to CD8 T cells
por: Gourdain, P, et al.
Publicado: (2012)

Forced primer selection modulates HIV-1 replication and stability of the PBS
por: Ni, Na, et al.
Publicado: (2006)

The antisense protein of HTLV-2 positively modulates HIV-1 replication
por: Torresilla, Cynthia, et al.
Publicado: (2014)

P16-40. Inhibition of histone deacetylases modulates CD8+ T-lymphocyte mediated virus suppression by HIV-1 viral controllers
por: Saunders, KO, et al.
Publicado: (2009)

Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant
por: Fernandez-Ortega, C, et al.
Publicado: (2010)

P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)

Therapy of the patients with HIV/TB infection and dynamics of level 'naïve' CD4-lymphocytes
por: Popova, AA, et al.
Publicado: (2010)

Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
por: Erhabor, Osaro, et al.
Publicado: (2009)

Differential effects on HIV replication and T cell activation following direct inhibition of CDK9 or flavopiridol (FVP) treatment in primary peripheral blood lymphocytes
por: Salerno, D, et al.
Publicado: (2006)

A role for the tetraspanin CD81 on the late steps of HIV-1 replication in T-lymphoblastic cells
por: Muriaux, Delphine
Publicado: (2010)

P18-03. Dendritic cell-based immune therapy against HIV-1
por: Gruters, RA, et al.
Publicado: (2009)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
por: Bayer, Michael, et al.
Publicado: (2014)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

P16-39. T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy
por: Moraes, SL, et al.
Publicado: (2009)

Human herpesvirus 8 replicates in primary B lymphocytes and induces polyfunctional cytokine and chemokine responses
por: Knowlton, Emilee, et al.
Publicado: (2012)

P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection
por: Tudor, D, et al.
Publicado: (2009)

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
por: Hulot, SL, et al.
Publicado: (2012)

Vpr content of HIV-1 virions determines infection of resting peripheral blood CD4(+) lymphocytes
por: Van Nuffel, Anouk, et al.
Publicado: (2013)

Apoptotic microparticles generated during acute HIV-1 infection inhibit human dendritic cells via CD44
por: Frleta, D, et al.
Publicado: (2012)

Alpha-1-proteinase inhibitor regulates CD4 lymphocyte levels and is rate limiting in HIV-1 disease
por: Bristow, Cynthia L, et al.
Publicado: (2012)

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission
por: Goh, J, et al.
Publicado: (2013)

The CD85j(+) NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
por: Scott-Algara, Daniel, et al.
Publicado: (2008)

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
por: Lederle, Alexandre, et al.
Publicado: (2014)

Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
por: Dillman, Robert, et al.
Publicado: (2014)

Safety, feasibility and functionality of activated autologous dendritic cells for intratumoral injection in solid tumors: a Phase I clinical trial
por: Subbiah, Vivek, et al.
Publicado: (2015)

Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment
por: Subbiah, Vivek, et al.
Publicado: (2014)

T cell contact-mediated induction of tumor necrosis factor alpha in peripheral blood monocytes is inhibited by autologous serum in rheumatoid arthritis
por: Wagner, U, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_qjuop872srddu541c9muuige4b